HP
MIRM icon

HealthInvest Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

HealthInvest Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
100,807
-94,961
-49% -$9.53M 3.18% 10
2026
Q1 		$9.4M Buy
195,768
+106,083
+118% +$9.98M 3.03% 12
2025
Q4 		$7.08M Sell
89,685
-3,920
-4% -$281K 2.26% 18
2025
Q3 		$6.86M Sell
93,605
-13,307
-12% -$846K 2.7% 16
2025
Q2 		$5.44M Buy
106,912
+29,649
+38% +$1.32M 2.33% 16
2025
Q1 		$3.48M Sell
77,263
-39,429
-34% -$1.86M 1.54% 21
2024
Q4 		$4.81M Sell
116,692
-21,629
-16% -$901K 2.28% 15
2024
Q3 		$5.39M Buy
138,321
+63,121
+84% +$2.52M 2.54% 17
2024
Q2 		$2.57M Sell
75,200
-47,800
-39% -$1.25M 1.57% 19
2024
Q1 		$3.09M Buy
+123,000
New +$3.38M 1.88% 19

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HealthInvest Partners's MIRM Position: Q2 2026 in Review

HealthInvest Partners reduced its Mirum Pharmaceuticals (MIRM) stake by 49% in Q2 2026, selling an estimated $9.53M and leaving 100,807 shares worth $11.8M. The position accounts for 3.18% of the portfolio, ranked #10.

HealthInvest Partners first reported a position in MIRM in Q1 2024 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • HealthInvest Partners held 100,807 shares of Mirum Pharmaceuticals worth $11.8M as of Q2 2026.
  • HealthInvest Partners sold 94,961 Mirum Pharmaceuticals shares in Q2 2026, an estimated $9.53M.
  • Mirum Pharmaceuticals made up 3.18% of HealthInvest Partners's portfolio in Q2 2026, its #10 holding.
  • HealthInvest Partners first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.